financetom
Business
financetom
/
Business
/
Onex Q3 net earnings drop
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Onex Q3 net earnings drop
Nov 7, 2025 4:36 AM

Overview

* Onex ( ONEXF ) Q3 net earnings decline to $39 mln from $127 mln year-over-year

* Company acquires majority interest in Convex Group, partners with AIG

* Asset management fee-related earnings rise to $11 mln from $6 mln

Outlook

* Onex ( ONEXF ) expects Convex acquisition to enhance growth and profitability

* Company anticipates significant value creation from partnerships with AIG

Result Drivers

* PRIVATE EQUITY RETURNS - Onex's ( ONEXF ) private equity teams returned capital to investors through strategic realizations, contributing to overall performance

* CREDIT TEAM PERFORMANCE - Onex's ( ONEXF ) credit team raised or extended over $10 bln in capital this year, bolstering Q3 results

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 EPS $0.57

Q3 Net $39 mln

Income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the investment management & fund operators peer group is "buy"

* Wall Street's median 12-month price target for Onex Corp ( ONEXF ) is C$165.00, about 28.7% above its November 6 closing price of C$117.65

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Visa prevented $40 billion worth of fraudulent transactions in 2023- official
Visa prevented $40 billion worth of fraudulent transactions in 2023- official
Jul 23, 2024
JOHANNESBURG (Reuters) - Visa prevented 80 million fraudulent transactions worth $40 billion globally last year thanks to investments in technology including artificial intelligence (AI), a senior company figure said on Tuesday. In 2025, cybercrime is projected to cost the world $10.5 trillion. If this were a nation's gross domestic product, it would rank as the world's third-largest economy, Charles Lobo,...
Solis Minerals Announces Extensive Geophysical Survey for its Guaneros Project in Peru
Solis Minerals Announces Extensive Geophysical Survey for its Guaneros Project in Peru
Jul 23, 2024
12:03 PM EDT, 07/23/2024 (MT Newswires) -- Solis Minerals ( SLMFF ) last seen down 9.1%, on Tuesday provided an update on exploration activities at the recently claimed Guaneros Project in Peru. The company contracted a geophysical contractor to carry out a maiden drone airborne magnetometry survey to assist in fast-tracking target generation, identify zones for further geophysical follow-up, and...
Market Chatter: Italy Seizes $131.3 Million From Amazon Unit Over Alleged Tax, Labor Offences
Market Chatter: Italy Seizes $131.3 Million From Amazon Unit Over Alleged Tax, Labor Offences
Jul 23, 2024
12:05 PM EDT, 07/23/2024 (MT Newswires) -- Italy's tax police seized 121 million euros ($131.3 million) from Amazon.com's ( AMZN ) Amazon Italia Transport logistic services subsidiary as part of a probe into alleged tax fraud and illegal labor practices, Reuters reported Tuesday, citing prosecutor documents. The Milan Prosecutors' Office said Amazon Italia allegedly circumvented labor and tax laws and...
AstraZeneca Secures Global License for Pinetree's Novel Cancer Candidate
AstraZeneca Secures Global License for Pinetree's Novel Cancer Candidate
Jul 23, 2024
12:03 PM EDT, 07/23/2024 (MT Newswires) -- AstraZeneca ( AZN ) has entered into an exclusive option and global license agreement with Pinetree Therapeutics for a preclinical epidermal growth factor receptor, or EGFR, degrader candidate, Pinetree said Tuesday. Under the terms of the agreement, Pinetree will receive upfront and near-term payments of up to $45 million and will be eligible...
Copyright 2023-2026 - www.financetom.com All Rights Reserved